(Q40219455)

18 September 2017

1 reference

title

Cefoperazone: A review of its in vitro antimicrobial activity, pharmacological properties and therapeutic efficacy (English)

1 reference

18 September 2017

1

R N Brogden

1 reference

18 September 2017

A Carmine

2

1 reference

18 September 2017

R C Heel

3

1 reference

18 September 2017

P A Morley

4

1 reference

18 September 2017

T M Speight

5

1 reference

18 September 2017

G S Avery

6

1 reference

18 September 2017

1 December 1981

1 reference

18 September 2017

1 reference

18 September 2017

22

1 reference

18 September 2017

6

1 reference

18 September 2017

423-460

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-198122060-00002

18 September 2017

0 references

cites work

Cefotaxime kinetics after intravenous and intramuscular injection of single and multiple doses

1 reference

12 December 2020

A Comparative Study of the Activity of Cefamandole and Other Cephalosporins and Analysis of the -Lactamase Stability and Synergy of Cefamandole with Aminoglycosides

1 reference

12 December 2020

[Results of application of cefoperazone to pediatric infections (author's transl)]

1 reference

12 December 2020

Microbiological studies on cefoperazone

1 reference

12 December 2020

Activity of beta-lactamase produced by Bacteroides fragilis against newly introduced cephalosporins

1 reference

12 December 2020

Clinical experience with cefoperazone in biliary tract infections.

1 reference

12 December 2020

Antabuse effect with cephalosporins

1 reference

12 December 2020

Effect of inoculum size and beta-lactamase production on in vitro activity of new cephalosporins against Haemophilus species

1 reference

12 December 2020

Disulfiram-like reaction associated with a parenteral cephalosporin

1 reference

12 December 2020

[Pharmacokinetic study of a cephalosporin, cefoperazone, in liver failure]

1 reference

12 December 2020

[Clinical studies on cefoperazone in gynecological field (author's transl)]

1 reference

12 December 2020

Comparative pharmacokinetics of cefoperazone and cefotaxime

1 reference

12 December 2020

Clinical studies with cefoperazone in the treatment of bacterial infections in surgical practice

1 reference

12 December 2020

Clinical trials with cefoperazone in the field of internal medicine in Japan

1 reference

12 December 2020

Comparison of antibacterial activity of a new cephalosporin, ceftizoxime (FK 749) with other cephalosporin antibiotics

1 reference

12 December 2020

Pharmacokinetics, protein binding, and predicted extravascular distribution of moxalactam in normal and renal failure subjects

1 reference

12 December 2020

Clinical results of cefoperazone in pediatric infections (author's transl)

1 reference

12 December 2020

Cefoperazone concentrations in bile and gall bladder wall after intravenous administration

1 reference

12 December 2020

Clinical comparison of cefoperazone in complicated urinary tract infections using a double-blind method.

1 reference

12 December 2020

Antibacterial activity of ceftizoxime, a beta-lactamase-stable cephalosporin

1 reference

12 December 2020

Clinical trials with cefoperazone in the field of surgery in Japan

1 reference

12 December 2020

Studies on protein binding of antibiotics. I. Effect of cefazolin on protein binding and pharmacokinetics of cefoperazone

1 reference

12 December 2020

Disulfiram-like reaction to a cephalosporin

1 reference

12 December 2020

Cefoperazone: pharmacokinetics in humans with normal and impaired renal function and pharmacokinetics in rats

1 reference

12 December 2020

Comparison of cefotaxime and moxalactam pharmacokinetics and tissue levels

1 reference

12 December 2020

A study of cefoperazone alone and in combination with tobramycin against Pseudomonas aeruginosa

1 reference

12 December 2020

Anomalous effect of serum on the antimicrobial activity of cefoperazone

1 reference

12 December 2020

Comparison of the activity of cefoperazone, cefuroxime and cefoxitin against Gram-negative bacilli and synergy studies with cefoperazone and ticarcillin

1 reference

12 December 2020

Synergistic activity of cefoperazone in combination with β-lactamase inhibitors

1 reference

12 December 2020

Human pharmacology of cefotaxime (HR 756), a new cephalosporin

1 reference

12 December 2020

Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteria

1 reference

12 December 2020

Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilli

1 reference

12 December 2020

[Subacute toxicity test of cefoperazone in beagle dogs with the intramuscular administration for 3 months (author's transl)]

1 reference

12 December 2020

[Clinical studies of cefoperazone in pediatric field (author's transl)]

1 reference

12 December 2020

Cefoperazone in Klebsiella meningitis: a case report

1 reference

12 December 2020

Clinical studies on cefoperazone treatment for bile duct infections (author's transl)

1 reference

12 December 2020

A clinical trial with cefoperazone in pneumonia and pyelonephritis

1 reference

12 December 2020

[Clinical studies on cefoperazone in the pediatric field (author's transl)]

1 reference

12 December 2020

[Cefoperazone concentration in infected tissues and clinical effect for patients with peritonitis (author's transl)].

1 reference

12 December 2020

In vitro and in vivo antibacterial activity of cefoperazone

1 reference

12 December 2020

A review and summary of the pharmacokinetics of cefoperazone: a new, extended-spectrum beta-lactam antibiotic

1 reference

12 December 2020

Pharmacokinetics of a new cephalosporin, cefoperazone

1 reference

12 December 2020

Comparison of the β-lactamase stability and the in-vitro activity of cefoperazone, cefotaxime, cefsulodin, ceftazidime, moxalactam and ceftriaxone against Pseudomonas aeruginosa

1 reference

12 December 2020

Cefoperazone (T-1551), a new semisynthetic cephalosporin: comparison with cephalothin and gentamicin

1 reference

12 December 2020

Cefoperazone: absorption, excretion, distribution, and metabolism

1 reference

12 December 2020

Single-dose pharmacokinetics of cefoperazone following intravenous administration

1 reference

12 December 2020

Comparative activity of cefoperazone against selected cephalosporinase-producing enteric bacteria

1 reference

12 December 2020

In-vitro antibacterial activity of cefoperazone, a piperazine cephalosporin

1 reference

12 December 2020

Comparative Activity and β-Lactamase Stability of Cefoperazone, a Piperazine Cephalosporin

1 reference

12 December 2020

Decreased extrarenal clearance of cefoperazone in hepatocellular diseases

1 reference

12 December 2020

[Treatment of whooping cough and whooping cough syndrome by cefoperazone (author's transl)]

1 reference

12 December 2020

[Clinical evaluation of cefoperazone in children (author's transl)]

1 reference

12 December 2020

Laboratory and clinical studies on cefoperazone in pediatrics treatment (author's transl)

1 reference

12 December 2020

Potential value of cefoperazone in bacterial meningitis: experimental studies

1 reference

12 December 2020

Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli

1 reference

12 December 2020

[Clinical examination of cefoperazone in pediatrics (author's transl)]

1 reference

12 December 2020

Inhibitory concentrations of cefoperazone, cefazolin, cefamandole, cephaloridine, and cefoxitin for 300 gram-negative clinical isolates

1 reference

12 December 2020

In vitro evaluation of cefoperazone

1 reference

12 December 2020

Susceptibilities of anaerobic bacteria to cefoperazone and other antibiotics

1 reference

12 December 2020

Pharmacokinetics of moxalactam and cefazolin compared in normal volunteers

1 reference

12 December 2020

Fundamental and clinical studies of cefoperazone in children (author's transl)

1 reference

12 December 2020

Susceptibility of anaerobic bacteria to cefoperazone and other beta-lactam antibiotics

1 reference

12 December 2020

Antimicrobial activity and spectrum of cefoperazone against recent clinical isolates

1 reference

12 December 2020

Cefoperazone in the treatment of severe or complicated infections

1 reference

12 December 2020

Worldwide clinical experience with cefoperazone

1 reference

12 December 2020

Clinical studies on cefoperazone in gynecological and obstetrical field (author's transl)

1 reference

12 December 2020

[Fundamental and clinical studies of cefoperazone in pediatric patients (author's transl)].

1 reference

12 December 2020

The in vitro antibacterial activity of LY127935 (6059S), a novel 1-oxa-beta-lactam antibiotic

1 reference

12 December 2020

A study of the in vitro activity of cefoperazone: a comparison with other beta-lactam antibiotics

1 reference

12 December 2020

In vitro activity of a new semisynthetic cephalosporin: cefoperazone.

1 reference

12 December 2020

Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa

1 reference

12 December 2020

Bactericidal activity of cefoperazone in comparison with other beta-lactam antibiotics and gentamicin

1 reference

12 December 2020

Cefoperazone in lower respiratory tract infections

1 reference

12 December 2020

Antibacterial activity of ceftizoxime (FK 749), a new cephalosporin, against cephalosporin-resistant bacteria, and its stability to beta-lactamase

1 reference

12 December 2020

Cefoperazone: evaluation of the in vitro activity and an analysis of the disk diffusion test

1 reference

12 December 2020

In-vitro activity of cefoperazone and penicillins alone and in combination with aminoglycosides against Pseudomonas aeruginosa

1 reference

12 December 2020

[Subacute toxicity test of cefoperazone in beagle dogs with the intravenous administration for 3 months (author's transl)]

1 reference

12 December 2020

Pharmacokinetics of moxalactam in subjects with normal and impaired renal function

1 reference

12 December 2020

Serum and urine concentrations of cefoperazone in severe chronic renal failure

1 reference

12 December 2020

In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains

1 reference

12 December 2020

[Clinical studies on cefoperazone in otorhinolaryngological field (author's transl)]

1 reference

12 December 2020

[Antibacterial activity of cefoperazone against anaerobic bacteria (author's transl)].

1 reference

12 December 2020

Experimental and clinical studies on cefoperazone (author's transl)

1 reference

12 December 2020

[Clinical experience with cefoperazone in the pediatric field (author's transl)].

1 reference

12 December 2020

Affinity of cefoperazone for penicillin-binding proteins

1 reference

12 December 2020

<i>In vitro</i> Comparison of Three New Cephalosporins: LY-127935, Cefotaxime and Cefoperazone

1 reference

12 December 2020

Pharmacokinetics and Bacteriologic Efficacy of Moxalactam, Cefotaxime, Cefoperazone, and Rocephin in Experimental Bacterial Meningitis

1 reference

12 December 2020

[Clinical studies of cefoperazone in the treatment of pyoderma (author's transl)].

1 reference

12 December 2020

Comparative Activities of the Oxa-β-Lactam LY127935, Cefotaxime, Cefoperazone, Cefamandole, and Ticarcillin Against Multiply Resistant Gram-Negative Bacilli

1 reference

12 December 2020

Comparison of in vitro activities of eight beta-lactamase-stable cephalosporins against beta-lactamase-producing gram-negative bacilli

1 reference

12 December 2020

[Laboratory and clinical studies of cefoperazone in children (author's transl)].

1 reference

12 December 2020

Pharmacology of a new 1-oxa-beta-lactam (LY127935) in normal volunteers

1 reference

12 December 2020

Kinetics of cefotaxime in healthy subjects (author's transl)

1 reference

12 December 2020

In vitro antibacterial activity of cefoperazone (T-1551), a new semisynthetic cephalosporin

1 reference

12 December 2020

10.2165/00003495-198122060-00002

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hquxnfpvnraeplepygyrfg5mme

30 July 2022

mapped directly with Wikidata item

Dimensions Publication ID

1020556299

0 references

Fatcat ID

release_hquxnfpvnraeplepygyrfg5mme

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hquxnfpvnraeplepygyrfg5mme

30 July 2022

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/hquxnfpvnraeplepygyrfg5mme

30 July 2022